What is the recommended protocol for massive transfusion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Massive Transfusion Protocol

The recommended massive transfusion protocol should follow a high-ratio transfusion strategy of at least 1:1:1 or 1:1:2 (RBC:plasma:platelets) with implementation of a well-defined hospital protocol to improve communication, facilitate timely delivery of blood products, and reduce morbidity and mortality. 1, 2

Definition of Massive Transfusion

  • Massive blood loss is defined as:
    • Loss of one blood volume within a 24-hour period (approximately 7% of ideal body weight in adults)
    • 50% blood volume loss within 3 hours
    • Blood loss occurring at a rate of 150 ml/min 1
  • Alternative definition: Administration of 10 or more units of red blood cells in less than 24 hours 3

Key Components of Massive Transfusion Protocol

Initial Assessment and Management

  1. Immediate Actions:

    • Control obvious bleeding points using direct pressure, tourniquets, and hemostatic dressings
    • Administer high concentration oxygen
    • Establish large-bore IV access (at least two sites)
    • Obtain baseline blood tests including CBC, PT, APTT, fibrinogen levels, and blood typing 1
  2. Blood Product Administration:

    • Use warmed blood products (critical to prevent hypothermia-induced coagulopathy)
    • Follow blood product availability order: O-negative → type-specific → cross-matched 1

Transfusion Ratios and Strategy

  • Recommended ratio: 1:1:1 or 1:1:2 (RBC:plasma:platelets) 1, 2
  • This balanced approach helps prevent and treat coagulopathy rather than treating it after development 3, 2
  • Target laboratory values:
    • Fibrinogen levels >1.5 g/L
    • Platelet count >75 × 10⁹/L
    • Consider platelet transfusion for significant active bleeding 1

Monitoring and Adjunctive Management

  1. Laboratory Monitoring:

    • Repeat coagulation tests every 30-60 minutes during active bleeding
    • Consider viscoelastic testing (TEG/ROTEM) for more rapid assessment of coagulopathy 1, 4
  2. Temperature Management:

    • Actively warm the patient
    • Warm all transfused fluids to prevent hypothermia 1
  3. Electrolyte Management:

    • Monitor and correct hypocalcemia and hypomagnesemia, which frequently occur with massive transfusion 1
  4. Post-Transfusion Care:

    • Admit to critical care for monitoring
    • Regularly assess coagulation parameters, hemoglobin, and blood gases
    • Monitor wound drains to identify ongoing bleeding
    • Initiate standard venous thromboprophylaxis once bleeding is controlled 1

Evidence-Based Considerations

The PROPPR trial and subsequent studies have confirmed the benefits of balanced transfusion ratios 2. While the 2018 systematic review 5 found insufficient evidence to definitively recommend 1:1:1 over 1:1:2 ratio, more recent evidence from 2020 2 and 2024 4 supports the use of balanced ratios between 1:1:1 and 1:1:2.

Implementation Considerations

  • Having a formal, written massive transfusion protocol improves outcomes 1, 6
  • Faster blood product delivery correlates with better patient outcomes 2
  • Consider keeping emergency blood products readily available in trauma bays 2
  • The protocol should be well-communicated to all staff involved in trauma care 1

Common Pitfalls to Avoid

  • Delayed activation: Failure to recognize massive hemorrhage early can lead to worse outcomes
  • Unbalanced transfusion: Giving only RBCs without appropriate plasma and platelets can worsen coagulopathy
  • Inadequate warming: Cold blood products exacerbate coagulopathy
  • Neglecting calcium: Citrate in stored blood products binds calcium, requiring supplementation
  • Failing to reassess: Continuous monitoring of coagulation status is essential to guide ongoing therapy

References

Guideline

Management of Persistent Bleeding after Percutaneous Nephrolithotomy (PCNL)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Massive transfusion protocol in adult trauma population.

The American journal of emergency medicine, 2020

Research

Massive transfusion in trauma.

Current opinion in anaesthesiology, 2024

Research

Massive transfusion protocol: Need of the hour - A tertiary care centre experience.

Journal of anaesthesiology, clinical pharmacology, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.